Quanfeng Wu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 4
-
- Circular RNAs in diseases 3
- Extracellular vesicles in disease 2
- RNA modifications and cancer 1
- Cancer-related gene regulation 1
- Genomics, phytochemicals, and oxidative stress 1
-
- Cancer Mechanisms and Therapy 1
- Partner nations
- China
In The Last Decade
Quanfeng Wu
6 papers receiving 580 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 423
- Molecular Biology 490
- Immunology 130
- Molecular Medicine 25
- Oncology 52
Countries citing papers authored by Quanfeng Wu
This map shows the geographic impact of Quanfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanfeng Wu more than expected).
Fields of papers citing papers by Quanfeng Wu
This network shows the impact of papers produced by Quanfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanfeng Wu. The network helps show where Quanfeng Wu may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Quanfeng Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2022 | 0 | |
| 3 | Norwogonin flavone suppresses the growth of human colon cancer cells via mitochondrial mediated apoptosis, autophagy induction and triggering G2/M phase cell cycle arrest. | 2021 | 4 |
| 4 | 2017 | 80 | |
| 5 | 2016 | 71 | |
| 6 | 2016 | 303 | |
| 7 | 2016 | 119 |
About Quanfeng Wu
Quanfeng Wu is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Molecular Biology, having authored 7 papers that have together received 581 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers), Extracellular vesicles in disease (2 papers), RNA modifications and cancer (1 paper), Cancer-related gene regulation (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Cancer Research (423 citations), Molecular Biology (490 citations) and Immunology (130 citations). Quanfeng Wu has collaborated with scholars based in China. Frequent co-authors include Weixing Wang, Xiang Tian, Gao Liu, Ying Xiang, Xinjing Wang, Xiaoli Wu, Xipeng Wang, Qinyi Zhu, Lu Jiang and Xin Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.